Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Chan

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|November 15, 2019
Regional brain volumetric changes despite 2 years of treatment initiated during acute HIV infectionKalpana J Kallianpur, Neda Jahanshad, Napapon Sailasuta, et al.
AIDS Research and Therapy|February 7, 2025
Impaired creatinine-based estimated glomerular filtration rate in Thai individuals switching to dolutegravir: illustrating the role of cystatin C testing to aid clinical decision makingCarlo Sacdalan, Curtis Austin, Aswathy Varma, et al.
Journal of Neurovirology|January 29, 2020
Resting-state neural signatures of depressive symptoms in acute HIVCarissa L Philippi, Leah Reyna, Laura Nedderman, et al.
Psychiatry Research Communications|June 29, 2026
A psychometric assessment of the Patient Health Questionnaire-9 for people living with acutely-treated HIV in ThailandTyler Hamby, Suteera Pinyakorn, Seth Frndak, et al.
AIDS Research and Therapy|December 31, 2022
Effects of syphilis infection among HIV-1-positive individuals on suppressive antiretroviral therapyPhillip Chan, Tommy H C Tang, Ruby T S Kwong, et al.
The Journal of Infectious Diseases|June 6, 2018
Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological AbnormalitiesMichelle L D'Antoni, Mary Margaret Byron, Phillip Chan, et al.
Brain, Behavior, & Immunity - Health|August 14, 2025
Inside out: TNFa-RII and sexualized drug use in acute HIV predicts persistent depressive symptoms despite antiretroviral therapyJennifer V Chavez, Jacob Bolzenius, Phillip Chan, et al.
AIDS (London, England)|February 1, 2023
Brain volumetrics differ by Fiebig stage in acute HIV infectionJacob Bolzenius, Carlo Sacdalan, Lishomwa C Ndhlovu, et al.
HIV Medicine|May 4, 2026
Real-world clinical and laboratory changes after switching to two-drug regimen in HIV-suppressed individuals: 48 weeks and beyondTommy Hing-Cheung Tang, Ruby Tsz-Shan Kwong, Phillip Chan, et al.
Psychosomatic Medicine|September 26, 2022
Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV InfectionRobert Paul, Kyu Cho, Jacob Bolzenius, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|November 15, 2019
Regional brain volumetric changes despite 2 years of treatment initiated during acute HIV infectionKalpana J Kallianpur, Neda Jahanshad, Napapon Sailasuta, et al.
AIDS Research and Therapy|February 7, 2025
Impaired creatinine-based estimated glomerular filtration rate in Thai individuals switching to dolutegravir: illustrating the role of cystatin C testing to aid clinical decision makingCarlo Sacdalan, Curtis Austin, Aswathy Varma, et al.
Journal of Neurovirology|January 29, 2020
Resting-state neural signatures of depressive symptoms in acute HIVCarissa L Philippi, Leah Reyna, Laura Nedderman, et al.
Psychiatry Research Communications|June 29, 2026
A psychometric assessment of the Patient Health Questionnaire-9 for people living with acutely-treated HIV in ThailandTyler Hamby, Suteera Pinyakorn, Seth Frndak, et al.
AIDS Research and Therapy|December 31, 2022
Effects of syphilis infection among HIV-1-positive individuals on suppressive antiretroviral therapyPhillip Chan, Tommy H C Tang, Ruby T S Kwong, et al.
The Journal of Infectious Diseases|June 6, 2018
Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological AbnormalitiesMichelle L D'Antoni, Mary Margaret Byron, Phillip Chan, et al.
Brain, Behavior, & Immunity - Health|August 14, 2025
Inside out: TNFa-RII and sexualized drug use in acute HIV predicts persistent depressive symptoms despite antiretroviral therapyJennifer V Chavez, Jacob Bolzenius, Phillip Chan, et al.
AIDS (London, England)|February 1, 2023
Brain volumetrics differ by Fiebig stage in acute HIV infectionJacob Bolzenius, Carlo Sacdalan, Lishomwa C Ndhlovu, et al.
HIV Medicine|May 4, 2026
Real-world clinical and laboratory changes after switching to two-drug regimen in HIV-suppressed individuals: 48 weeks and beyondTommy Hing-Cheung Tang, Ruby Tsz-Shan Kwong, Phillip Chan, et al.
Psychosomatic Medicine|September 26, 2022
Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV InfectionRobert Paul, Kyu Cho, Jacob Bolzenius, et al.
Pageof 6